Organon (OGN) Consolidated Net Income (2020 - 2026)

Organon (OGN) has reported Consolidated Net Income for 6 consecutive years, with $146.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Consolidated Net Income rose 67.82% year-over-year to $146.0 million; the TTM figure through Mar 2026 stood at $246.0 million (down 67.2% YoY), while the FY2025 annual figure was $187.0 million, down 78.36% from the prior year.
• Consolidated Net Income came in at $146.0 million for Q1 2026 at Organon, up from -$205.0 million in the prior quarter.
• The five-year high for Consolidated Net Income was $546.0 million in Q4 2023, with the low at -$205.0 million in Q4 2025.
• Average Consolidated Net Income over 4 years is $170.8 million, with a median of $160.0 million recorded in 2025.
• Across the five-year window, Consolidated Net Income jumped 518.97% in 2024 and slumped 288.07% in 2025, its largest moves.
• Year by year, Consolidated Net Income stood at $546.0 million in 2023, then sank by 80.04% to $109.0 million in 2024, then plunged by 288.07% to -$205.0 million in 2025, then jumped by 171.22% to $146.0 million in 2026.
• According to Business Quant data, Consolidated Net Income over the past three periods registered $146.0 million, -$205.0 million, and $160.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.